Parkman Healthcare Partners’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.53M | Sell |
8,811
-1,421
| -14% | -$408K | 0.29% | 76 |
|
|
2025
Q1 | $3.15M | Sell |
10,232
-27,240
| -73% | -$8.4M | 0.37% | 63 |
|
|
2024
Q4 | $13.2M | Sell |
37,472
-26,559
| -41% | -$9.37M | 1.76% | 19 |
|
|
2024
Q3 | $22.9M | Sell |
64,031
-47,350
| -43% | -$17M | 2.93% | 7 |
|
|
2024
Q2 | $35.5M | Sell |
111,381
-16,818
| -13% | -$5.36M | 4.75% | 3 |
|
|
2024
Q1 | $29.4M | Sell |
128,199
-33,340
| -21% | -$7.66M | 3.61% | 2 |
|
|
2023
Q4 | $35.5M | Buy |
161,539
+23,211
| +17% | +$5.1M | 5% | 2 |
|
|
2023
Q3 | $31.2M | Buy |
138,328
+15,350
| +12% | +$3.47M | 5.72% | 2 |
|
|
2023
Q2 | $27.1M | Buy |
122,978
+14,906
| +14% | +$3.29M | 4.71% | 1 |
|
|
2023
Q1 | $24.2M | Buy |
108,072
+7,370
| +7% | +$1.65M | 5.26% | 1 |
|
|
2022
Q4 | $28M | Buy |
100,702
+18,432
| +22% | +$5.13M | 7.46% | 1 |
|
|
2022
Q3 | $17.2M | Sell |
82,270
-9,536
| -10% | -$2M | 4.9% | 1 |
|
|
2022
Q2 | $21.6M | Buy |
91,806
+17,699
| +24% | +$4.17M | 7.97% | 1 |
|
|
2022
Q1 | $13.3M | Sell |
74,107
-16,091
| -18% | -$2.89M | 3.89% | 2 |
|
|
2021
Q4 | $19.5M | Sell |
90,198
-4,126
| -4% | -$892K | 4.3% | 2 |
|
|
2021
Q3 | $17.4M | Hold |
94,324
| – | – | 4.4% | 4 |
|
|
2021
Q2 | $16.9M | Buy |
94,324
+19,450
| +26% | +$3.49M | 3.7% | 5 |
|
|
2021
Q1 | $12.5M | Buy |
+74,874
| New | +$12.5M | 2.91% | 9 |
|